• Recent
  • Class
  • Inventors
  • Assignees
  • Top Lists
  • Pricing
  • Account
Patents-Review.com
  1. Home
  2. Inventor
  3. K
  4. Koh…
  5. KOHLER Mark Eric
🔗 Permalink
Inventor profile of:

Mark Eric KOHLER

City:

Denver, Colorado

Country:

United States

Published Applications:

5

Last publication date:

2026-02-05

Recent patent applications by KOHLER Mark Eric

Mark Eric KOHLER from Denver, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-02-05
US20260034217A1
Human necessities

COMPOSITIONS AND METHODS FOR THE TREATMENT OF VEN/AZA RESISTANT ACUTE MYELOID LEUKEMIA

#2 | 2025-07-24
US20250235535A1
Human necessities

COMPOSITIONS AND METHODS FOR THE TREATMENT OF VEN/AZA RESISTANT ACUTE MYELOID LEUKEMIA

#3 | 2025-01-30
US20250032615A1
Human necessities

ANTI-CD56 AND ANTI-CD99 LOGIC GATED CHIMERIC ANTIGEN RECEPTORS FOR THE TREATMENT OF CANCER

#4 | 2025-01-30
US20250032612A1
Human necessities

ANTI-CD276 AND ANTI-CD99 LOGIC GATED CHIMERIC ANTIGEN RECEPTORS FOR THE TREATMENT OF CANCER

#5 | 2024-11-28
US20240390419A1
Human necessities

CD3 EPSILON CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE THEREOF

InventorID:

6848909 ⎘

  1. Home
  2. Inventor
  3. K
  4. Koh…
  5. KOHLER Mark Eric

Some parts © 2022-2026 Patents-Review.com

Browse & Discovery
  • Home
  • Patent Classification
  • Inventor Index
  • Assignee Index
  • Interesting Applications
Search & Tools
  • Basic Search
  • Advanced Search
  • Patent Alerts
  • Top Lists
  • Statistics
Information & Resources
  • About US Patent System
  • Terms & Privacy
  • Pricing
  • Contact
Quick Access
  • Latest Applications
  • Top Inventors 2026
  • Top Assignees 2026
  • Featured Patents
Disclaimer: This website is intended for informational purposes only, and its content is based on public patent records. Please note that some sections of this website have been created or processed using machine learning models. We provide content in good faith but make no guarantees regarding accuracy or completeness. By using this site, you accept any risks and waive claims against us for errors or omissions.